Ir para o conteúdo principal

United States Últimas notícias

Todas as matérias desta categoria, das mais recentes às mais antigas.

Grafa
Health

ADC Therapeutics secures cash runway to 2028 amid pivotal clinical momentum

ADC Therapeutics (NYSE: ADCT), a commercial-stage biotechnology company improving the lives of cancer patients with its next-generation antibody-drug conjugates (ADCs), reported a steady fourth quarter for 2025 and a significantly strengthened balance sheet on Tuesday.

Leia mais: ADC Therapeutics secures cash runway to 2028 amid pivotal clinical momentum
Grafa
Health

Q32 Bio extends cash runway to 2027 following program sale and financing

Q32 Bio (NASDAQ:QTTB), a clinical-stage biotechnology company developing therapies for autoimmune and inflammatory diseases, provided a fourth-quarter 2025 corporate update that highlights a significantly strengthened balance sheet and clinical progress.

Leia mais: Q32 Bio extends cash runway to 2027 following program sale and financing
Grafa
Retail

United Natural Foods posts higher profit despite sales dip following optimization

United Natural Foods (NYSE:UNFI), the largest publicly traded wholesale distributor of health and specialty foods in North America, reported a significant increase in profitability for its fiscal second quarter ended January 31, 2026.

Leia mais: United Natural Foods posts higher profit despite sales dip following optimization